Log in
Enquire now
‌

US Patent 7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Patent 7247301 was granted and assigned to Genmab A/S on July, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
‌
Genmab A/S
Date Filed
June 13, 2002
Date of Patent
July 24, 2007
Patent Application Number
10172317
Patent Citations Received
‌
US Patent 11987615 Modified immunoglobulins
0
‌
US Patent 11981744 Chimeric polypeptide assembly and methods of making and using the same
0
‌
US Patent 11753476 Combination therapy for cancers with BRAF mutation
‌
US Patent 11713358 Chimeric polypeptide assembly and methods of making and using the same
0
‌
US Patent 11771762 Anti-ErbB3 antibodies and uses thereof
‌
US Patent 11932685 Fc variants with altered binding to FcRn
0
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
Patent Inventor Names
Arnout F. Gerritsen
0
Edward Halk
0
Jan G. J. van de Winkel
0
Marcus A. van Dijk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7247301
Patent Primary Examiner
‌
Eileen B. O'Hara

Find more entities like US Patent 7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.